Michel, L. L., Hartkopf, A. D., Fasching, P. A., Kolberg, H., Hadji, P., Tesch, H., . . . Taran, F. (2020). Progression-Free Survival and Overall Survival in Patients with Advanced HER2-Positive Breast Cancer Treated with Trastuzumab Emtansine (T-DM1) after Previous Treatment with Pertuzumab. Friedrich-Alexander-Universität Erlangen-Nürnberg.
Chicago-Zitierstil (17. Ausg.)Michel, Laura L., et al. Progression-Free Survival and Overall Survival in Patients with Advanced HER2-Positive Breast Cancer Treated with Trastuzumab Emtansine (T-DM1) After Previous Treatment with Pertuzumab. Erlangen ; Nürnberg: Friedrich-Alexander-Universität Erlangen-Nürnberg, 2020.
MLA-Zitierstil (9. Ausg.)Michel, Laura L., et al. Progression-Free Survival and Overall Survival in Patients with Advanced HER2-Positive Breast Cancer Treated with Trastuzumab Emtansine (T-DM1) After Previous Treatment with Pertuzumab. Friedrich-Alexander-Universität Erlangen-Nürnberg, 2020.